Comparisons between RT-PCR, Real-time PCR, and In Vitro Globin Chain Synthesis by α/β Ratio Calculation for Diagnosis of α- from β-thalassemia Carriers

Maryami, Fereshteh; Mahdian, Reza; Jamali, Somayeh; Karimi Arzanani, Mohsen; Khatami, Shohreh; Maryami, Fahimeh; Bayat, Parastou; Sadeghi, Sedigheh; Karimipour, Morteza; Zeinali, Sirous
April 2013
Archives of Iranian Medicine (AIM);Apr2013, Vol. 16 Issue 4, p217
Academic Journal
Background: Thalassemia, which may be due to point mutations, translocations, and deletions involving the α or βglobin gene, is the most prevalent single gene disorder in Iran. This study aims to calculate the α/β ratio in normal cases, α- and β-thalassemia carriers by RT-PCR, real-time PCR, and in vitro globin chain synthesis (GCS) in order to establish the most accurate technique to distinguish between α- and β-thalassemia carriers in suspicious cases. Methods: The α/β ratios were calculated in all samples by RT-PCR, real-time RT-PCR, and in vitro GCS. Results: Using RT-PCR, the ratios were 1.09 ± 0.07 in normal samples, 1.2 ± 0.17 in β-thalassemia, 1.08 +0.19 in mild α-thalassemia, and 0.96 ± 0.19 in severe a-thalassemia carriers. In real-time RT-PCR, the ratios were 2.21 ± 1.36 in normal samples, 5.12 ± 1.83 in β-thalassemia, 2.88 ±0.81 in mild α-thalassemia, and 1.18 ±0.52 in severe α-thalassemia carriers. With GCS, the ratios were 1.03 ±0.1 in normal samples, 1.9 ± 0.37 in β-thalassemia, 0.8 ± 0.13 in mild α-thalassemia, and 0.59 ± 0.12 in severe α-thalassemia carriers. Conclusion: To determine the most accurate technique, we statistically analyzed the α/β ratios obtained from the three standard methods. The ratio obtained by GCS and real-time PCR were helpful in distinguishing between α and β carriers in suspicious patients in whom the mutation detection was limited and the risk for offspring was not clear. The use of this technique is more obvious when time is restricted (i.e. during the pregnancy period)


Related Articles

  • Co-Existence of Hereditary Pyrimidine 5'-Nucleotidase Deficiency and Heterozygous α-Thalassemia: A Case Presentation. Agapidou, A.; Theodoridou, S.; Tegos, K.; Mandala, E.; Leukou, E.; Karakasidou, O.; Aletra, B.; Sevastidou, A.; Alemayehou, M.; Voskaridou, E. // Turkish Journal of Hematology;Dec2012, Vol. 29 Issue 4, p434 

    A letter to the editor is presented which is concerned with a case presentation of a 25 year old female patient who exhibited co-existence of hereditary pyrimidine 5'-nucleotidase deficiency and heterozygous a-thalassemia.

  • First report from Turkey of a rare frameshift mutation [codons 9/10 (+T)] in the beta-globin gene. Güneşaçar, Ramazan; Çelik, M. Murat // Turkish Journal of Hematology;Dec2011, Vol. 28 Issue 4, p343 

    A letter to the editor is presented which is concerned with a Turkish patient with a frameshift mutation in the beta-globin gene.

  • Relationship between neonatal screening results by HPLC and the number of α-thalassaemia gene mutations; consequences for the cut-off value. Bouva, M. J.; Sollaino, C.; Perseu, L.; Galanello, R.; Giordano, P. C.; Harteveld, C. L.; Cnossen, M. H.; Schielen, P. C. J. I.; Elvers, L. H.; Peters, M. // Journal of Medical Screening;Dec2011, Vol. 18 Issue 4, p182 

    Objectives To evaluate the relationship between FAST peak percentage by adapted Bio-Rad Vnbs analysis using the valley-to-valley integration and genotypes with the aim to improve differentiation between severe a-thalassaemia forms (HbH disease) and the milder disease types. Method DNA analysis...

  • Polymerase Chain Reaction for the Detection of Histamine- Producing Bacteria Isolated from Taiwanese Foods. HSIEN-FENG KUNG; TSONG-MING LEE; CHUNG-SAINT LIN; TANG-YAO HONG; YUNG-HSIANG TSAI // Journal of Food & Drug Analysis;Mar2012, Vol. 20 Issue 1, p74 

    It is important to develop rapid methods to detect the presence of histamine producers. In this study, the polymerase chain reaction (PCR) assay yielded a 367-bp DNA amplification fragment from histidine decarboxylase (hdc) of gram-positive bacteria using JV16HC/JV17HC primer, and 534-bp and...

  • About Pyrimidine 5'-Nucleotidase Deficiency. Özsoylu, Şinasi // Turkish Journal of Hematology;Jun2013, Vol. 30 Issue 2, p227 

    A letter to the editor is presented in response to the article "Co-Existence of Hereditary Pyrimidine 5’-Nucleotidase Deficiency and Heterozygous α-Thalassemia: A Case Presentation" by A. Agapidou et al.

  • The effect of genetic polymorphisms in UGT2B15 on the pharmacokinetic profile of sipoglitazar, a novel anti-diabetic agent. Stringer, Frances; Scott, Graham; Valbuena, Marian; Kinley, Judith; Nishihara, Mitsuhiro; Urquhart, Richard // European Journal of Clinical Pharmacology;Mar2013, Vol. 69 Issue 3, p423 

    Purpose: Sipoglitazar was a novel, azolealkanoic acid derivative that possesses selective activity for the peroxisome proliferator-activated receptors (PPAR) PPARγ, PPARα, and PPARδ. The compound undergoes phase II biotransformation by conjugation catalyzed by...

  • Screening for β-thalassaemia trait in coastal Karnataka: A population based study. Shenoy, U. V.; Coutinho, Anita; Raj, Bharath // International Journal of the A.J. Institute of Medical Sciences;May2013, Vol. 2 Issue 1, p61 

    The haemoglobinopathies are a group of inherited conditions (autosomal codominant) that result in the synthesis of either a globin chain with an abnormal structure (structural variant) or reduced synthesis of a globin chain with normal structure, leading to chain imbalance (the thalassemia...

  • HbA2measurements in β-thalassemia and in other conditions. Ivaldi, Giovanni; Barberio, Giuseppina; Harteveld, Cornelis L.; Giordano, Piero C. // Thalassemia Reports;2014, Vol. 4 Issue 2, p45 

    Quite a few papers have been written on the significance of elevated hemoglobin (Hb) A2 as a parameter for the diagnosis of β-thalassemia trait, on the cutoff values to be used in diagnostics and on the significance and effects of factors reducing or elevating the expression of HbA2 and last...

  • The effect of Hββ:c.*+96T>C (3'UTR + 1570 T>C) on the mild β-thalassemia intermedia phenotype. Bilgen, Türker; Canatan, Duran; Arıkan, Yunus; Yeşilipek, Akif; Keser, İbrahim // Turkish Journal of Hematology;Sep2011, Vol. 28 Issue 3, p219 

    Hemoglobin beta (HBB):c.*+96T>C substitution is very rare among β-globin gene mutations and its clinical significance remains to be clarified. The present study aimed to investigate the role of HBB:c.*+96T>C in the β-thalassemia intermedia phenotype in a Turkish family. The proband and...


Read the Article


Sorry, but this item is not currently available from your library.

Try another library?
Sign out of this library

Other Topics